Morton Coleman

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Richard R. Furman, Steven Coutré et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

Medicine, Hematology, Oncology +12

Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib

John C. Byrd, Richard R. Furman, Steven Coutré et al. · Blood · 2015 · 656 citations

Medicine, Pharmacology, Pharmacotherapy +8

Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial

Susan O’Brien, Richard R. Furman, Steven Coutré et al. · The Lancet Oncology · 2013 · 465 citations

Medicine, Immunology, Oncology +10

PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.

Lale Kostakoğlu, Morton Coleman, John P. Leonard et al. · PubMed · 2002 · 367 citations

Medicine, Nuclear Medicine, Oncology +17

Persistent and Relapsing Babesiosis in Immunocompromised Patients

Peter J. Krause, Benjamin E. Gewurz, David R. Hill et al. · Clinical Infectious Diseases · 2007 · 353 citations

Veterinary Medicine, Immunology, Infectious Diseases +15